Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06580054
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-18
Brief Title:
Pembrolizumab for the Treatment of Locally Advanced andor Recurrent Orbital or Periocular Cutaneous Squamous Cell Carcinoma
Sponsor:
Organization:
None